Roundtable Discussion: Harmonizing the Exosome & Extra-Cellular Vesicle Regulatory Landscape Towards Better Definitions, Practices & Guidelines for Therapeutic Success
Time: 9:30 am
day: Conference Day Two
Details:
- What are the current gaps in knowledge of submissions, and what can we learn from current therapeutic progress in the clinic?
- How does the current regulatory guidance provide clarity on CMC changes for exosome-based therapeutics?
- How can the exosome biopharma industry and regulators continue to support each other to ensure global harmony and better therapeutics to patients faster?
